For the Inventor, By the Inventor

Enter assignee name

Leuven, Belgium

K.u. Leuven Research & Development

USPTO Granted Patents = 84

% Expired Patents = 57.1

CIPO Patents = 6

EPO Patents = 38

Forward Citations = 1,559

Loading Chart...

Loading Chart...

184 inventors (with patents filed for the assignee):

David A Oare (10 out of 32 patents)

Steven S Bondy (9 out of 20 patents)

Erik De Clercq (9 out of 13 patents)

4. Piet Herdewijn (8 out of 19 patents)

5. Jan Balzarini (7 out of 35 patents)

6. Johan Neyts (6 out of 29 patents)

7. Vahid Zia (6 out of 20 patents)

8. Ignace H Verpoest (6 out of 6 patents)

9. Johan Adriaan Martens (5 out of 36 patents)

10. Tongfei Wu (5 out of 28 patents)

11. Christophe Pannecouque (5 out of 7 patents)

12. Roger Bouillon (5 out of 9 patents)

13. Christopher McGuigan (4 out of 38 patents)

14. Winston C Tse (4 out of 39 patents)

15. Eric Dowdy (4 out of 17 patents)

Core Competencies:

Antiviral Compounds

Nucleoside Derivatives

Viral Inhibitors

Phosphonate Nucleosides

Controlled Release

Imidazo Compounds

Bioactive Agents

Pharmaceutical Compositions

Gene Therapy

Infectious Diseases

Drug Development

Therapeutic Agents

84 patents: Sort by Forward Citations

1. 11174497 - Yeast alleles involved in tolerance to high alcohol levels (2021-11-16),

2. 10087209 - Antiviral compounds, a process for their preparation, and their use for treating viral infections (2018-10-02),

3. 9522932 - Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production (2016-12-20),

4. 9427447 - Anti-viral pyrimidine nucleoside derivatives (2016-08-30),

5. 9249177 - Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production (2016-02-02),

6. 9242983 - Viral inhibitors (2016-01-26),

7. 8884011 - Nucleotide analogues as precursor molecules for antivirals (2014-11-11),

8. 8859512 - Anti-viral pyrimidine nucleoside derivatives (2014-10-14),

9. 8809520 - Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production (2014-08-19),

10. 8795806 - Half closed thermoplastic honeycomb, their production process and equipment to produce (2014-08-05),

11. 8790697 - Controlled release delivery system for bio-active agents (2014-07-29),

12. 8779141 - Viral inhibitors (2014-07-15),

13. 8722677 - Viral inhibitors (2014-05-13),

14. 8670619 - Robust interest point detector and descriptor (2014-03-11),

15. 8658616 - Nucleoside aryl phosphoramidates and their use as anti-viral agents for the treatment of hepatitis C virus (2014-02-25),

Company Overview

K.u. Leuven Research & Development is a prominent research institution located in Leuven, Belgium, specializing in the development of antiviral compounds. The organization focuses on innovative technologies related to nucleoside derivatives, viral inhibitors, and phosphonate nucleosides, contributing significantly to pharmaceutical advancements. Their research encompasses controlled release systems and bioactive agents, aiming to enhance therapeutic efficacy in combating viral infections. K.u. Leuven's commitment to scientific excellence positions it as a leader in the field of antiviral research.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

84 Patents

#4 in Leuven

#62 in Belgium

#9,067 in the World

Leuven, Belgium

K.u. Leuven Research & Development

Forward Citations = 1,559

184 inventors:

David A Oare (10 out of 32 patents)

Steven S Bondy (9 out of 20 patents)

Erik De Clercq (9 out of 13 patents)

4. Piet Herdewijn (8 out of 19 patents)

5. Jan Balzarini (7 out of 35 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: K.u. Leuven Research & Development. Retrieved from https://idiyas.com/company/k-u-leuven-research-and-development

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…